Screener
Aura Biosciences, Inc. AURA Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Aura Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The source filing: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216808
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Accrued expenses and other current liabilities | 10,866 | 13,591 |
| Total current liabilities | 16,706 | 18,383 |
| Long-term operating lease liability | 13,724 | 14,134 |
| Total Liabilities | 30,430 | 32,517 |
| Commitments and Contingencies (Note 12) | ||
| Stockholders’ Equity: | ||
| Common stock, $0.00001 par value, 150,000,000 authorized at March 31, 2026 and December 31, 2025, and 64,150,468 and 63,587,777 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | — | — |
| Additional paid-in capital | 621,557 | 617,433 |
Item 1. Financial Statements.
FAQ
- What is Aura Biosciences, Inc.'s total liabilities?
- Aura Biosciences, Inc. (AURA) reported total liabilities of $30.43M in Q1 2026.
- How has Aura Biosciences, Inc.'s total liabilities changed year-over-year?
- Aura Biosciences, Inc.'s total liabilities increased by 10.9% year-over-year, from $27.44M to $30.43M.
- What is the long-term trend for Aura Biosciences, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), Aura Biosciences, Inc.'s total liabilities has grown at a 64.0% compound annual growth rate (CAGR), from $2.74M to $32.52M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about Aura Biosciences, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude